Waldenström macroglobulinemia/lymphoplasmacytic lymphoma, version 2.2024, NCCN Clinical Practice Guidelines in Oncology Guidelines
| Authors: | Kumar, S. K.; Callander, N. S.; Adekola, K.; Anderson, L. D. Jr; Baljevic, M.; Baz, R.; Campagnaro, E.; Castillo, J. J.; Costello, C.; D'Angelo, C.; Derman, B.; Devarakonda, S.; Elsedawy, N.; Garfall, A.; Godby, K.; Hillengass, J.; Holmberg, L.; Htut, M.; Huff, C. A.; Hultcrantz, M.; Kang, Y.; Larson, S.; Lee, H.; Liedtke, M.; Martin, T.; Omel, J.; Robinson, T.; Rosenberg, A.; Sborov, D.; Schroeder, M. A.; Sherbenou, D.; Suvannasankha, A.; Valent, J.; Varshavsky-Yanovsky, A. N.; Snedeker, J.; Kumar, R. |
| Title: | Waldenström macroglobulinemia/lymphoplasmacytic lymphoma, version 2.2024, NCCN Clinical Practice Guidelines in Oncology |
| Abstract: | The treatment of Waldenström macroglobulinemia/lymphoplasmacytic lymphoma (WM/LPL) has evolved to include several new options. The NCCN Guidelines for WM/LPL provide a framework on which to base decisions regarding diagnosis, treatment, assessment of response to treatment, and follow-up of both newly diagnosed and previously treated WM/LPL. |
| Keywords: | waldenstroem macroglobulinemia; b cell lymphoma; lymphoma, b-cell; waldenstrom macroglobulinemia; humans; human |
| Journal Title: | Journal of the National Comprehensive Cancer Network |
| Volume: | 22 |
| Issue: | 1D |
| ISSN: | 1540-1405 |
| Publisher: | Harborside Press |
| Date Published: | 2024-01-01 |
| Start Page: | e240001 |
| Language: | English |
| DOI: | 10.6004/jnccn.2024.0001 |
| PUBMED: | 38244272 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Article -- Source: Scopus |
